<?xml version="1.0" encoding="UTF-8"?>
<ref id="B110-vaccines-08-00273">
 <label>110.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Suschak</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Bagley</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Six</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Shoemaker</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Kwilas</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Spik</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Dupuy</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Schmaljohn</surname>
    <given-names>C.S.</given-names>
   </name>
  </person-group>
  <article-title>The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>159</volume>
  <fpage>113</fpage>
  <lpage>121</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.09.014</pub-id>
  <pub-id pub-id-type="pmid">30268913</pub-id>
 </element-citation>
</ref>
